市場調查報告書
商品編碼
1438032
皮膚科影像設備市場至2030年的預測:按產品、模式、技術、應用、最終用戶和地區的全球分析Dermatology Imaging Devices Market Forecasts to 2030 - Global Analysis By Product, Modality, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的資料,2023年全球皮膚科影像設備市場規模將達到 86.2 億美元,預計到2030年將達到 125.4 億美元,預測期內年複合成長率為 14.7%。
皮膚科影像設備在皮膚病的診斷和監測中發揮重要作用。這些設備利用先進技術提供皮膚結構的詳細影像。皮膚科醫生使用這些非侵入性工具來檢查痣、病變和皮膚異常,以幫助及早發現皮膚癌和其他皮膚病問題。高解析度影像可提高診斷準確性,促進更有效的治療計劃,並有助於改善皮膚科患者的治療效果。
根據美國癌症協會2022年統計資料,2022年美國將通報新發皮膚黑色素瘤病例99,780例。其中,57,180 例為男性,42,600 例為女性。
皮膚病增加
由於人口老化、生活方式的改變和污染,皮膚病的發生率不斷增加,準確有效的診斷技術在皮膚病學中變得越來越必要。隨著醫療保健相關人員尋求最尖端科技來準確、及時地診斷皮膚病,皮膚科影像設備市場顯著擴大。這些設備支援非侵入性測試並提高皮膚科實踐的整體效率,為應對日益頻繁的皮膚問題而不斷成長的市場做出了貢獻。
進入醫療機構受到限制
在醫療基礎設施有限的地區,患者在獲得及時的皮膚病診斷和治療方面面臨挑戰。獲得醫療保健的不平等也加劇了皮膚病的負擔,因為患者可能會延遲接受適當的皮膚病治療。這一障礙對服務不足的地區造成了不成比例的影響,加劇了醫療保健差距並抑制了市場的成長潛力。
提高人們對美容護理的認知和關注
人們對皮膚健康和吸引力的日益重視增加了皮膚科對技術改進的診斷成像設備的需求。這些工具對於識別和追蹤皮膚問題非常重要,可以幫助專業人士提供精確和客製化的美容療程。隨著人們越來越注重實現最佳美容效果,由於醫學和美容進步的交叉,皮膚科影像設備市場預計將持續成長。
先進影像處理設備高成本
取得和維護最尖端科技的高昂成本限制了醫療保健提供者和設施的可及性。這種經濟障礙阻礙了普及,並阻止小型診所和醫療機構投資最先進的皮膚病成像設備。因此,資源分配不均可能阻礙皮膚科先進診斷能力的整體發展和可近性,損害患者照護和診斷準確性。
COVID-19 的影響
COVID-19 的疫情對市場產生了各種影響。雖然醫療保健服務的中斷和新冠相關資源的優先排序最初導致需求下降,但對遠端醫療和遠距離診斷的日益關注導致了市場的復甦。此次疫情凸顯了皮膚科影像在虛擬諮詢中的重要性,導致採用率激增。然而,供應鏈中斷和經濟不確定性繼續對皮膚科影像設備領域的市場成長構成挑戰。
預計皮膚科領域將在預測期內成為最大的細分市場。
皮膚科內視鏡領域預計將出現良好的成長。皮膚鏡是皮膚科醫師用來檢查皮膚病變和異常的手持設備。這些放大儀器提供皮膚的特寫視圖,使專業人士更清楚地評估痣、色素病變和其他皮膚狀況。皮膚鏡有多種接觸式和非接觸式設計,在皮膚病診斷中發揮重要作用,有助於做出有關皮膚健康的更準確、更明智的決策。其攜帶性和易用性使其成為常規皮膚檢查的寶貴工具。
皮膚癌診斷領域預計在預測期內年複合成長率最高
預計皮膚癌診斷領域在預測期內將出現最高的年複合成長率。皮膚科影像設備透過提供非侵入性、高解析度的皮膚影像,在皮膚癌診斷中發揮非常重要的作用。這些設備可幫助皮膚科醫生準確評估皮膚病變,區分良性和惡性生長,並確定最佳切片檢查位置。該技術增強了早期檢測,及時干預並改善預後。此外,這些設備還可以最大程度地減少不必要的切片檢查,減少患者的不適和醫療費用。
由於人們對皮膚健康的認知不斷提高以及皮膚病患病率的上升,預計亞太地區將在預測期內佔據最大的市場佔有率。 Minolta 和 Nidek Corporation 等該地區的主要參與者投資研發,推動影像解決方案的創新。醫療基礎設施的改善和可支配收入的增加也有助於市場擴張。此外,對非侵入性和高效診斷工具的需求獲得市場動力,中國、日本和印度等國家成為該地區皮膚科成像設備市場的主要貢獻者。
預計北美在預測期內的年複合成長率最高。由於技術進步和皮膚病患病率上升,該地區呈現強勁成長。北美人口老化嚴重。美國、加拿大等新興國家擁有優惠的償付政策和完善的醫療基礎設施。此外,醫療保健基礎設施的監管支持和進步也在北美皮膚科影像設備市場的蓬勃發展中發揮著非常重要的作用。
According to Stratistics MRC, the Global Dermatology Imaging Devices Market is accounted for $8.62 billion in 2023 and is expected to reach $12.54 billion by 2030 growing at a CAGR of 14.7% during the forecast period. Dermatology imaging devices play a crucial role in diagnosing and monitoring skin conditions. These devices utilize advanced technologies to provide detailed images of the skin's structure. Dermatologists use these non-invasive tools to examine moles, lesions, and skin abnormalities, aiding in the early detection of skin cancers and other dermatological issues. The high-resolution imaging helps enhance diagnostic accuracy and facilitates more effective treatment planning, contributing to improved patient outcomes in the field of dermatology.
According to the American Cancer Society's 2022 statistics, in the United States, an estimated 99,780 new cases of melanoma of the skin are expected to be reported in 2022. Of those, 57,180 cases are likely to be registered among males and 42,600 in females.
Growing incidence of skin disorders
Accurate and effective diagnostic techniques are becoming a growing necessity in dermatology as skin disorders grow more common as a result of aging populations, changes in lifestyle, and pollution. As medical professionals look for cutting-edge technologies for accurate and timely diagnosis of skin conditions, the market for dermatology imaging devices is expanding significantly. Contributing to the market's expansion in response to the rising frequency of skin problems, these devices aid in non-invasive inspection, improving the overall efficiency of dermatological practices.
Limited access to healthcare facilities
In regions with restricted healthcare infrastructure, patients face challenges in obtaining timely dermatological diagnoses and treatments. The disparity in healthcare access also exacerbates the burden of skin diseases, as patients may experience delays in receiving proper dermatological care. This barrier disproportionately affects underserved regions, exacerbating healthcare disparities and impeding the market's potential growth.
Rising awareness & focus on aesthetic procedures
Technologically improved imaging instruments in dermatology are in greater demand as people place greater emphasis on skin health and attractiveness. These tools are essential for identifying and tracking skin issues, which helps professionals provide accurate and customized cosmetic procedures. With a heightened focus on achieving optimal cosmetic outcomes, the market for dermatology imaging devices is poised for sustained growth, driven by the intersection of medical and aesthetic advancements.
High cost of advanced imaging devices
The prohibitive expenses associated with acquiring and maintaining cutting-edge technology limit accessibility for healthcare providers and facilities. This financial barrier hampers widespread adoption, hindering smaller clinics and healthcare institutions from investing in state-of-the-art dermatology imaging equipment. As a result, the unequal distribution of resources may impede the overall growth and accessibility of advanced diagnostic capabilities in dermatology, potentially compromising patient care and diagnostic accuracy.
Covid-19 Impact
The covid-19 pandemic has had a mixed impact on the market. While there was an initial decline in demand due to disrupted healthcare services and prioritization of covid-related resources, the market rebounded with an increased focus on telemedicine and remote diagnostics. The pandemic underscored the importance of dermatological imaging for virtual consultations, leading to a surge in adoption. However, supply chain disruptions and economic uncertainties continue to pose challenges for market growth in the dermatology imaging devices sector.
The dermatoscopes segment is expected to be the largest during the forecast period
The dermatoscopes segment is estimated to have a lucrative growth. Dermatoscopes are handheld devices used by dermatologists to examine skin lesions and abnormalities. These magnifying instruments provide a close-up view of the skin, enabling professionals to assess moles, pigmented lesions, and other skin conditions with enhanced clarity. With varying designs, including contact and non-contact models, dermatoscopes play a crucial role in dermatological diagnostics, facilitating more accurate and informed decisions about skin health. Their portability and ease of use make them valuable tools in routine skin examinations.
The skin cancer diagnosis segment is expected to have the highest CAGR during the forecast period
The skin cancer diagnosis segment is anticipated to witness the highest CAGR growth during the forecast period. Dermatology imaging devices play a pivotal role in skin cancer diagnosis by offering non-invasive, high-resolution images of the skin. These devices aid dermatologists in accurately assessing skin lesions, distinguishing benign from malignant growths, and determining optimal biopsy locations. The technology enhances early detection, leading to timely intervention and improved prognosis. Additionally, these devices minimize unnecessary biopsies, reducing patient discomfort and healthcare costs.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the growing awareness of skin health and a rising prevalence of dermatological conditions. Key players here namely Minolta and Nidek Corporation are investing in research and development, fostering innovation in imaging solutions. Also, improvements in healthcare infrastructure and rising disposable incomes contribute to the market expansion. Further, the demand for non-invasive and efficient diagnostic tools is fueling the market's momentum, with countries like China, Japan, and India emerging as key contributors to the region's dermatology imaging devices market.
North America is projected to have the highest CAGR over the forecast period. The region exhibits robust growth driven by technological advancements and a rising prevalence of skin disorders. North America has the presence of huge aging population. Emerging economies in the region such as United States and Canada has favourable reimbursement policies and a well-established healthcare infrastructure. Moreover, regulatory support and healthcare infrastructure advancements also play pivotal roles in shaping the thriving dermatology imaging devices market in North America.
Key players in the market
Some of the key players profiled in the Dermatology Imaging Devices Market include Derma Medical Systems, Danaher Corporation, Nikon Corporation, Canfield Scientific Inc., FotoFinder Systems GmbH, Carl Zeiss Meditec AG, 3Gen DermLite, Metaoptima Technology Inc., Strata Skin Sciences Company, Heine Optotechnik GmbH & Co. KG, Lucid Inc., ModiQuest Research and Michelson Diagnostics Company.
In October 2023, Danaher Corporation, has launched the patent-pending CellXpress.ai™ Automated Cell Culture System-an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab.
In April 2023, Nikon Corporation announced the development and launch of the digital imaging microscope "ECLIPSE Ui"*2 as the first-ever microscope for medical use in Japan. The ECLIPSE Ui has a unique design without an eyepiece lens (even though is a microscope), a design which improves the pathologist's observation posture and enables the sharing of observation images on the display.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.